IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland
Open accessThe DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Abstract
High serum levels of IL-6 correlate with poor outcome in breast cancer patients. However, no data are available on the relationship between IL-6 and mammary stem/progenitor cells, which may fuel the genesis of breast cancer in vivo. Herein, we address this issue in the MCF-7 breast cancer cell line and in primary human mammospheres (MS), multicellular structures enriched in stem/progenitor cells of the mammary gland. MS from node invasive breast carcinoma tissues expressed IL-6 mRNA at higher levels than did MS from matched non-neoplastic mammary glands. In addition, IL-6 mRNA was detected only in basal-like breast carcinoma tissues, an aggressive breast carcinoma variant showing stem cell features. IL-6 treatment triggered Notch-3-dependent upregulation of the Notch ligand Jagged-1 and promotion of MS and MCF-7-derived spheroid growth. Moreover, IL-6 induced Notch-3-dependent upregulation of the carbonic anhydrase IX gene and promoted a hypoxia-resistant/invasive phenotype in MCF-7 cells and MS. Finally, autocrine IL-6 signaling relied upon Notch-3 activity to sustain the aggressive features of MCF-7-derived hypoxia-selected cells. In conclusion, these data support the hypothesis that IL-6 induces malignant features in Notch-3-expressing stem/progenitor cells from human ductal breast carcinoma and normal mammary gland.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“IL-6 is an MSC-secreted inflammatory cytokine displaying pro-survival, pro-growth and pro-angiogenic activities [11], which has been implicated in tumor progression of various cancers including breast cancer [113, 114].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
ELSTON, C. W., & ELLIS, I. O. (1991) · Histopathology · doi:10.1111/j.1365-2559.1991.tb00229.x · Cited by 6,175
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Nielsen, T. O., Hsu, F. D., Jensen, K., Cheang, M., Karaca, G., Hu, Z., Hernandez-Boussard, T., Livasy, C., Cowan, D., Dressler, L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0220 · Cited by 2,663
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,406
Research works printed but not linked: 4
- Zhang, 1999, Anticancer Res., 19, 1427
- Sehgal, 1991, EXS., 59, 178
- Conze, 2001, Cancer Res., 61, 8851
- Trikha, 2003, Clin. Cancer Res., 9, 4653
Cited by
Items 101–200 of 839
Molecular pathways in cancer-related inflammation
Del Prete, A., Allavena, P., Santoro, G., Fumarulo, R., Corsi, M. M., & Mantovani, A. (2011) · Biochemia Medica · doi:10.11613/bm.2011.036 · Cited by 181
Picon-Ruiz, M., Pan, C., Drews-Elger, K., Jang, K., Besser, A. H., Zhao, D., Morata-Tarifa, C., Kim, M., Ince, T. A., Azzam, D. J., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-0927 · Cited by 180
IL-6: The Link Between Inflammation, Immunity and Breast Cancer
Chen, J., Wei, Y., Yang, W., Huang, Q., Chen, Y., Zeng, K., & Chen, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.903800 · Cited by 178
STAT3: a multifaceted oncoprotein
Guanizo, A. C., Fernando, C. D., Garama, D. J., & Gough, D. J. (2018) · Growth Factors · doi:10.1080/08977194.2018.1473393 · Cited by 174
Radharani, N. N. V., Yadav, A. S., Nimma, R., Kumar, T. V. S., Bulbule, A., Chanukuppa, V., Kumar, D., Patnaik, S., Rapole, S., & Kundu, G. C. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02527-9 · Cited by 174
Balko, J. M., Schwarz, L. J., Bhola, N. E., Kurupi, R., Owens, P., Miller, T. W., Gómez, H., Cook, R. S., & Arteaga, C. L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1385 · Cited by 157
Oh, K., Lee, O.-Y., Shon, S. Y., Nam, O., Ryu, P. M., Seo, M. W., & Lee, D.-S. (2013) · Breast Cancer Research · doi:10.1186/bcr3473 · Cited by 156
Neumeister, V. M., Agarwal, S., Bordeaux, J., Camp, R. L., & Rimm, D. L. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090712 · Cited by 172
Breast cancer stem cells: Multiple capacities in tumor metastasis
Geng, S.-Q., Alexandrou, A. T., & Li, J. J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.03.036 · Cited by 170
The times they’re a-changing: Effects of circadian desynchronization on physiology and disease
Golombek, D. A., Casiraghi, L. P., Agostino, P. V., Paladino, N., Duhart, J. M., Plano, S. A., & Chiesa, J. J. (2013) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2013.03.007 · Cited by 173
Liu, C., Lin, J., Hsu, T., Su, K., Li, A. F., Hsu, H., & Hung, S. (2015) · International Journal of Cancer · doi:10.1002/ijc.29033 · Cited by 169
Mesenchymal stem cell secretome and regenerative therapy after cancer
Zimmerlin, L., Park, T. S., Zambidis, E. T., Donnenberg, V. S., & Donnenberg, A. D. (2013) · Biochimie · doi:10.1016/j.biochi.2013.05.010 · Cited by 168
“IL-6 is an MSC-secreted inflammatory cytokine displaying pro-survival, pro-growth and pro-angiogenic activities [11], which has been implicated in tumor progression of various cancers including breast cancer [113, 114].”
BackgroundBurnett, J., Lim, G., Li, Y., Shah, R. B., Lim, R., Paholak, H. J., McDermott, S., Sun, L., Tsume, Y., Bai, S., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.02.023 · Cited by 169
Goel, H. L., Pursell, B., Chang, C., Shaw, L. M., Mao, J., Simin, K., Kumar, P., Kooi, C. W. V., Shultz, L. D., Greiner, D. L., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202078 · Cited by 167
Stromal Endothelial Cells Directly Influence Cancer Progression
Franses, J. W., Baker, A. B., Chitalia, V. C., & Edelman, E. R. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001542 · Cited by 166
Influence of IL-8 on The Epithelial–Mesenchymal Transition and the Tumor Microenvironment
Palena, C., Hamilton, D. H., & Fernando, R. I. (2012) · Future Oncology · doi:10.2217/fon.12.59 · Cited by 166
Reed, I. K. G., Phoenix, K. N., Hong, X., Tirnauer, J. S., Claffey, K. P., & White, B. A. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1534-y · Cited by 166
Inhibition of STAT3 Signaling Blocks the Anti-apoptotic Activity of IL-6 in Human Liver Cancer Cells
Liu, Y., Li, P.-K., Li, C., & Lin, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.142752 · Cited by 165
Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications
Zeng, X., Liu, C., Yao, J., Wan, H., Wan, G., Li, Y., & Chen, N. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105320 · Cited by 164
Lin, W.-H., Chang, Y.-W., Hong, M.-X., Hsu, T.-C., Lee, K.-C., Lin, C., & Lee, J.-L. (2021) · Oncogene · doi:10.1038/s41388-020-01566-8 · Cited by 164
Cisplatin Induces Bmi-1 and Enhances the Stem Cell Fraction in Head and Neck Cancer
Nör, C., Zhang, Z., Warner, K. A., Bernardi, L., Visioli, F., Helman, J. I., Roesler, R., & Nor, J. E. (2014) · Neoplasia · doi:10.1593/neo.131744 · Cited by 164
Jin, X., Yin, J., Kim, S.-H., Sohn, Y.-W., Beck, S., Lim, Y. C., Nam, D.-H., Choi, Y.-J., & Kim, H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1330 · Cited by 150
Notch Signaling Pathway as a Therapeutic Target in Breast Cancer
Al-Hussaini, H., Subramanyam, D., Reedijk, M., & Sridhar, S. S. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0677 · Cited by 163
Yang, H., Wang, B., Wang, T., Xu, L., He, C., Wen, H., Yan, J., Su, H., & Zhu, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109980 · Cited by 162
Wei, L., Liu, T.-T., Wang, H.-H., Hong, H.-M., Yu, A. L., Feng, H.-P., & Chang, W.-W. (2011) · Breast Cancer Research · doi:10.1186/bcr3042 · Cited by 162
Jin, G., Kawsar, H. I., Hirsch, S. A., Zeng, C., Jia, X., Feng, Z., Ghosh, S. K., Zheng, Q. Y., Zhou, A., McIntyre, T. M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010993 · Cited by 164
Molecular Mechanisms of Cancer-Induced Sleep Disruption
Walker, W. H., II, & Borniger, J. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112780 · Cited by 162
Detection and analysis of mammary gland stem cells
Stingl, J. (2009) · The Journal of Pathology · doi:10.1002/path.2457 · Cited by 161
Yin, X., Wolford, C. C., Chang, Y.-S., McConoughey, S. J., Ramsey, S. A., Aderem, A., & Hai, T. (2010) · Journal of Cell Science · doi:10.1242/jcs.064915 · Cited by 160
“demonstrated that mammospheres derived from invasive breast carcinoma expressed higher levels of IL6 than those from matched, non-neoplastic mammary glands (Sansone et al., 2007).”
BackgroundZacksenhaus, E., Shrestha, M., Liu, J. C., Vorobieva, I., Chung, P. E. D., Ju, Y., Nir, U., & Jiang, Z. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.09.002 · Cited by 160
Jin, S., Mutvei, A. P., Chivukula, I. V., Andersson, E. R., Ramsköld, D., Sandberg, R., Lee, K. L., Kronqvist, P., Mamaeva, V., Östling, P., et al. (2012) · Oncogene · doi:10.1038/onc.2012.517 · Cited by 157
Cancer and Aging - the Inflammatory Connection
Zinger, A., Cho, W. C., & Ben-Yehuda, A. (2017) · Aging and disease · doi:10.14336/ad.2016.1230 · Cited by 136
Jin, S., Nafees, M., Sun, Y., Tan, Y., Yuan, H., Song, D., Guo, Z., & Wang, X. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202011273 · Cited by 152
Molecular identification and targeting of colorectal cancer stem cells
Kemper, K., Grandela, C., & Medema, J. P. (2010) · Oncotarget · doi:10.18632/oncotarget.173 · Cited by 155
Interleukin-6: An angiogenic target in solid tumours
Middleton, K., Jones, J. E., Lwin, Z., & Coward, J. I. G. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.08.004 · Cited by 151
Balko, J. M., Schwarz, L. J., Luo, N., Estrada, M. V., Giltnane, J. M., Dávila-González, D., Wang, K., Sánchez, V., Dean, P. T., Combs, S. E., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad3001 · Cited by 136
Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities
Wang, Z., Tang, Y., Tan, Y., Wei, Q., & Yu, W. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0362-2 · Cited by 135
Indraccolo, S., Minuzzo, S. A., Masiero, M., Pusceddu, I., Persano, L., Moserle, L., Reboldi, A., Favaro, E., Mecarozzi, M., Mario, G. D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2791 · Cited by 150
Gu, Y., Mohammad, I., & Liu, Z. (2020) · Oncology Letters · doi:10.3892/ol.2020.11394 · Cited by 149
Izrailit, J., Berman, H. K., Datti, A., Wrana, J. L., & Reedijk, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214014110 · Cited by 147
Mammary Gland Growth Factors: Roles in Normal Development and in Cancer
Hynes, N. E., & Watson, C. J. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003186 · Cited by 146
Bao, B., Ahmad, A., Kong, D., Ali, S. S., Azmi, A. S., Li, Y., Banerjee, S., Padhyé, S., & Sarkar, F. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043726 · Cited by 145
Yu, C.-C., Tsai, L., Wang, M., Yu, C.-H., Lo, W., Chang, Y.-C., Chiou, G., Chou, M., & Chiou, S. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3840 · Cited by 145
BRD4 Regulates Breast Cancer Dissemination through Jagged1/Notch1 Signaling
Andrieu, G. P., Tran, A. H., Strissel, K. J., & Denis, G. V. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0559 · Cited by 145
Sansone, P., Berishaj, M., Rajasekhar, V. K., Ceccarelli, C., Chang, Q., Strillacci, A., Savini, C., Shapiro, L., Bowman, R. L., Mastroleo, C., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2129 · Cited by 137
Self-citationCellular senescence: hot or what?
Evan, G. I., & di Fagagna, F. D. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.11.009 · Cited by 151
Inflammation and cancer stem cells
Shigdar, S. L., Li, Y., Bhattacharya, S., O’Connor, M., Pu, C., Lin, J., Wang, T., Xiang, D., Kong, L., Wei, M. Q., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.031 · Cited by 139
Zhang, Q., Yamaza, T., Kelly, A., Shi, S., Wang, S., Brown, J., Wang, L., French, S. W., Shi, S., & Le, A. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007798 · Cited by 138
Hartman, Z. C., Yang, X.-Y., Glass, O., Lei, G., Osada, T., Dave, S. S., Morse, M. A., Clay, T. M., & Lyerly, H. K. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0308 · Cited by 137
“Our investigation also revealed that IL-6 secreted in response to HER2 expression was critical for HER2mediated transformation and activation of Stat3 in vitro and in vivo, a finding corroborated by other studies that show IL-6 mediation of transformative properties in mammary epithelial and tumor cells (7, 33).”
ResultXu, K., Usary, J., Kousis, P. C., Prat, A., Wang, D., Adams, J. R., Wang, W., Loch, A. J., Deng, T., Zhao, W., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.041 · Cited by 137
Side population and cancer stem cells: Therapeutic implications
Moserle, L., Ghisi, M., Amadori, A., & Indraccolo, S. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.05.020 · Cited by 135
A functional Notch–survivin gene signature in basal breast cancer
Lee, C. W., Simin, K. J., Liu, Q., Plescia, J., Guha, M., Khan, A. A., Hsieh, C., & Altieri, D. C. (2008) · Breast Cancer Research · doi:10.1186/bcr2200 · Cited by 135
Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer
Heo, T.-H., Wahler, J., & Suh, N. (2016) · Oncotarget · doi:10.18632/oncotarget.7102 · Cited by 122
Novel Dyskerin-Mediated Mechanism of p53 Inactivation through Defective mRNA Translation
Montanaro, L., Calienni, M., Bertoni, S., Rocchi, L., Sansone, P., Storci, G., Santini, D., Ceccarelli, C., Taffurelli, M., Carnicelli, D., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4024 · Cited by 134
Self-citationMatsumoto, S., Hara, T., Nagaoka, M., Mike, A., Mitsuyama, K., Sako, T., Yamamoto, M., KADO, S., & Takada, T. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.02942.x · Cited by 134
The association between obesity related adipokines and risk of breast cancer: a meta-analysis
Gui, Y., Pan, Q., Chen, X., Xu, S., Luo, X., & Chen, L. (2017) · Oncotarget · doi:10.18632/oncotarget.17853 · Cited by 132
Notch Signaling in Cancer Stem Cells
Wang, J., Sullenger, B. A., & Rich, J. N. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0899-4_13 · Cited by 132
Boareto, M., Jolly, M. K., Goldman, A., Pietilä, M., Mani, S. A., Sengupta, S., Ben-Jacob, E., Levine, H., & Onuchic, J. N. (2016) · Journal of The Royal Society Interface · doi:10.1098/rsif.2015.1106 · Cited by 123
Emerging roles for IL-11 signaling in cancer development and progression: Focus on breast cancer
Johnstone, C. N., Chand, A., Putoczki, T. L., & Ernst, M. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.015 · Cited by 117
Notch Signalling in Breast Development and Cancer
Edwards, A. R., & Brennan, K. R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.692173 · Cited by 130
ERα, microRNAs, and the epithelial–mesenchymal transition in breast cancer
Reed, I. K. G., Adams, B. D., & White, B. A. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.12.001 · Cited by 129
EGFR Blockade Enriches for Lung Cancer Stem–like Cells through Notch3-Dependent Signaling
Arasada, R. R., Amann, J. M., Rahman, M. A., Huppert, S. S., & Carbone, D. P. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3724 · Cited by 128
Metabolically activated adipose tissue macrophages link obesity to triple-negative breast cancer
Tiwari, P., Blank, A., Cui, C., Schoenfelt, K. Q., Zhou, G., Xu, Y., Khramtsova, G. F., Olopade, O. I., Shah, A. M., Khan, S. A., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20181616 · Cited by 129
Fan, G., Yu, B., Tang, L., Zhu, R., Chen, J., Zhu, Y., Huang, H., Zhou, L., Liu, J., Wang, W., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adj5705 · Cited by 128
Qureshi, R., Picon-Ruiz, M., Aurrekoetxea-Rodriguez, I., Nunes de Paiva, V., D’Amico, M., Yoon, H., Radhakrishnan, R., Morata-Tarifa, C., Ince, T., Lippman, M. E., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.05.008 · Cited by 127
Roles of NF-κB Signaling in the Regulation of miRNAs Impacting on Inflammation in Cancer
Markopoulos, G., Roupakia, E., Tokamani, M., Alabasi, G., Sandaltzopoulos, R., Marcu, K., & Kolettas, E. (2018) · Biomedicines · doi:10.3390/biomedicines6020040 · Cited by 110
Self-citationOuyang, G., Wang, Z., Fang, X., Liu, J., & Yang, C. J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0338-2 · Cited by 126
MiR-124 Suppresses Growth of Human Colorectal Cancer by Inhibiting STAT3
Zhang, J., Lu, Y., Yue, X., Li, H., Luo, X., Wang, Y., Wang, K., & Wan, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070300 · Cited by 127
Serum levels of IL-6, IL-8, and IL-10 are indicators of prognosis in pancreatic cancer
Feng, L., Qi, Q., Wang, P., Chen, H., Chen, Z., Meng, Z., & Liu, L. (2018) · Journal of International Medical Research · doi:10.1177/0300060518800588 · Cited by 125
ZEB 1‐regulated inflammatory phenotype in breast cancer cells
Katsura, A., Tamura, Y., Hokari, S., Harada, M., Morikawa, M., Sakurai, T., Takahashi, K., Mizutani, A., Nishida, J., Yokoyama, Y., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12098 · Cited by 124
West, N. R., Murray, J. I., & Watson, P. H. (2013) · Oncogene · doi:10.1038/onc.2013.105 · Cited by 124
Huang, C.-K., Yang, C.-Y., Jeng, Y., Chen, C.-L., Wu, H.-H., Chang, Y.-C., Ma, C., Kuo, W.-H., Chang, K.-J., Shew, J.-Y., et al. (2013) · Oncogene · doi:10.1038/onc.2013.268 · Cited by 123
DiNatale, B. C., Schroeder, J. C., Francey, L. J., Kusnadi, A., & Perdew, G. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.118570 · Cited by 109
Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells
Yeung, T. M., Gandhi, S. C., & Bodmer, W. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014519107 · Cited by 117
Franses, J. W., Drosu, N. C., Gibson, W. J., Chitalia, V. C., & Edelman, E. R. (2013) · International Journal of Cancer · doi:10.1002/ijc.28146 · Cited by 108
Cancer-Associated Fibroblasts Produce Netrin-1 to Control Cancer Cell Plasticity
Sung, P.-J., Rama, N., Imbach, J., Fiore, S., Ducarouge, B., Neves, D., Chen, H.-W., Bernard, D., Yang, P.-C., Bernet, A., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2952 · Cited by 103
Helm, J. S., & Rudel, R. A. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02752-z · Cited by 120
Nadal, R., Ortega, F. G., Salido, M., Lorente, J. A., Rodríguez‐Rivera, M., Delgado‐Rodríguez, M., Macià, M., Fernández, A., Corominas, J. M., García-Puche, J. L., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28263 · Cited by 117
Adams, B. D., Cowee, D. M., & White, B. A. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0062 · Cited by 118
Oh, K., Lee, O.-Y., Park, Y., Seo, M. W., & Lee, D. (2016) · BMC Cancer · doi:10.1186/s12885-016-2746-7 · Cited by 116
Jing, N., Du, Y., Chen, X., Bai, Q., Wang, Y., Zhang, X., Zhu, N., Zhang, J., Hou, J., Wang, Q. L., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0464 · Cited by 115
The Cancer Stem Cell Hypothesis: A Guide to Potential Molecular Targets
Allegra, A., Alonci, A., Penna, G., Innao, V., Gerace, D. G., Rotondo, F., & Musolino, C. (2014) · Cancer Investigation · doi:10.3109/07357907.2014.958231 · Cited by 117
Multifaceted Roles of Interleukin-6 in Adipocyte–Breast Cancer Cell Interaction
Gyamfi, J., Eom, M., Koo, J. S., & Choi, J. (2018) · Translational Oncology · doi:10.1016/j.tranon.2017.12.009 · Cited by 115
Nitric Oxide Is a Key Component in Inflammation-Accelerated Tumorigenesis
Hussain, S. P., He, P., Subleski, J., Hofseth, L. J., Trivers, G. E., Mechanic, L., Hofseth, A. B., Bernard, M., Schwank, J., Nguyen, G., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0410 · Cited by 108
Lin, Y., Jian, Z., Jin, H., Wei, X., Zou, X., Guan, R., & Huang, J. (2020) · Cell Death and Disease · doi:10.1038/s41419-019-2188-7 · Cited by 112
Toll-like receptor 2 mediates invasion via activating NF-κB in MDA-MB-231 breast cancer cells
Xie, W., Wang, Y., Huang, Y., Yang, H., Wang, J., & Hu, Z. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.009 · Cited by 112
Breast Cancer Stem Cells: Current Advances and Clinical Implications
Luo, M., Clouthier, S. G., Deol, Y. S., Liu, S., Nagrath, S., Azizi, E., & Wicha, M. S. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2519-3_1 · Cited by 114
Lin, C., Wang, L., Wang, H., Yang, L., Guo, H., & Wang, X. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24553 · Cited by 105
Baker, A., Wyatt, D., Bocchetta, M., Li, J., Filipovic, A., Green, A., Peiffer, D. S., Fuqua, S., Miele, L., Albain, K. S., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0251-y · Cited by 109
Wu, X., Zhang, W., Font-Burgada, J., Palmer, T. D., Hamil, A. S., Biswas, S. K., Poidinger, M., Borcherding, N. C., Xie, Q. M., Ellies, L. G., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414358111 · Cited by 111
Signaling pathways in breast cancer: Therapeutic targeting of the microenvironment
Kamdje, A. H. N., Etet, P. F. S., Vecchio, L., Jm, M., Krampera, M., & Lukong, K. E. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.07.034 · Cited by 112
Notch Signaling in Lung Development and Disease
Xu, K., Moghal, N., & Egan, S. E. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0899-4_7 · Cited by 109
Endothelial Interleukin-6 Defines the Tumorigenic Potential of Primary Human Cancer Stem Cells
Krishnamurthy, S., Warner, K. A., Dong, Z., Imai, A., Nör, C., Ward, B. B., Helman, J. I., Taichman, R. S., Bellile, E. L., McCauley, L. K., et al. (2014) · Stem Cells · doi:10.1002/stem.1793 · Cited by 109
Andersen, A. P., Moreira, J. M. A., & Pedersen, S. F. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0098 · Cited by 109
Bonafè, M., Storci, G., & Franceschi, C. (2012) · BioEssays · doi:10.1002/bies.201100104 · Cited by 94
Self-citationThe IL-6 feed-forward loop: A driver of tumorigenesis
Chang, Q., Daly, L., & Bromberg, J. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.007 · Cited by 108
Lim, S., Becker, A., Zimmer, A., Lu, J., Buettner, R., & Kirfel, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066558 · Cited by 90
Epigenetic Regulation of the miR142-3p/Interleukin-6 Circuit in Glioblastoma
Chiou, G., Chien, C., Wang, M., Chen, M.-T., Yang, Y., Yu, Y., Chien, Y., Chang, Y., Shen, C., Chio, C., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.11.009 · Cited by 106
Yang, Z., Guo, L., Liu, D., Sun, L., Chen, H., Deng, Q., Liu, Y., Yu, M., Ma, Y.-F., Guo, N., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.3241 · Cited by 105
The oncogenic role of Jagged1/Notch signaling in cancer
Xiu, M., Liu, Y., & Kuang, B. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110416 · Cited by 104
Metadata
- Authors
- Sansone, P., Storci, G., Tavolari, S., Guarnieri, T., Giovannini, C., Taffurelli, M., Ceccarelli, C., Santini, D., Paterini, P., Marcu, K. B., Chieco, P., & Bonafè, M.
- Affiliations
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- University of Bologna (IT)
- Corresponding author
- Bonafè, Massimiliano
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-12-03
- Volume
- 117
- Issue
- 12
- Pages
- 3988-4002
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2096439
- OpenAlex
- W2114817620
- Cited by
- 779
- References
- 61
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 21 · 2023: 29 · 2022: 27 · 2021: 27 · 2020: 55 · 2019: 40 · 2018: 55 · 2017: 52 · 2016: 45 · 2015: 64 · 2014: 71 · 2013: 70 · 2012: 53
- FWCI
- 15.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- Fondazione Cassa di Risparmio in Bologna
- Università di Bologna
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- interleukin-6, mammospheres, mammary stem/progenitor cells, breast ductal carcinoma, Notch3, Jagged1, carbonic anhydrase IX, hypoxia tolerance, breast cancer invasion, basal-like breast cancer, MCF-7 cells, autocrine signaling, tumor microenvironment
- MeSH terms
- Carbonic Anhydrase IX, Receptor, Notch3, Serrate-Jagged Proteins, Jagged-1 Protein, Antigens, Neoplasm, Breast Neoplasms, Calcium-Binding Proteins, Carbonic Anhydrases, Female, Humans, Membrane Proteins, Neoplasm Invasiveness, Neoplasm Proteins, RNA, Messenger, RNA, Neoplasm, Stem Cells, Cell Hypoxia, Interleukin-6, Up-Regulation, Gene Expression Regulation, Neoplastic, Spheroids, Cellular, Autocrine Communication, Intercellular Signaling Peptides and Proteins, Mammary Glands, Human, Carcinoma, Ductal, Cell Line, Tumor, Receptors, Notch
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.